Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
Operating Expenses | 8,431 | 5,982 | 4,386 | 6,572 | 7,714 |
Operating Income | -8,431 | -5,982 | -4,386 | -6,572 | -7,714 |
Interest Expense | 804 | 813 | 787 | 781 | 712 |
Other Income | 774 | 301 | -303 | 245 | 187 |
Pre-tax Income | -8,461 | -6,494 | -5,476 | -7,108 | -8,239 |
Net Income Continuous | -8,461 | -6,494 | -5,476 | -7,108 | -8,239 |
Net Income | $-8,461 | $-6,494 | $-5,476 | $-7,108 | $-8,239 |
EPS Basic Total Ops | -0.25 | -0.26 | -0.23 | -0.34 | -0.43 |
EPS Basic Continuous Ops | -0.25 | -0.26 | -0.23 | -0.34 | -0.43 |
EPS Diluted Total Ops | -0.25 | -0.26 | -0.23 | -0.34 | -0.43 |
EPS Diluted Continuous Ops | -0.25 | -0.26 | -0.23 | -0.34 | -0.43 |
EPS Diluted Before Non-Recurring Items | -0.25 | -0.26 | -0.26 | -0.34 | -0.43 |
EBITDA(a) | $-8,374 | $-5,925 | $-4,329 | $-6,514 | $-7,659 |